Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms; however, RSV can be very serious, especially for infants and older adults. No FDA-approved RSV vaccine exists, but with your help, we can help to advance vaccines and find a vaccine that will help prevent this virus.
QR Code Link to This Post
CTT is currently enrolling for an RSV Vaccine Research Study for women.
Qualified participants receive study-related vaccine, assessments and care from a board-certified physician at no cost.
You may be eligible if you:
• Are a healthy female, ages 18-49
• Know if/when you have had previous tetanus, diphtheria and pertussis (whooping cough) vaccinations.
• Are not pregnant or breastfeeding
• Are in general good health
Compensation up to $200 is available for time and travel
For more information contact:
Clinical Trials of Texas, Inc. (CTT)
show contact info
or apply online at